- Article
- Source: Campus Sanofi
RCT Evidence on Time-In-Range in Type 1 Diabetes


Amar Puttanna - RCT Evidence
RCT Evidence on Time-In-Range in Type 1 Diabetes
Length: 13:04
Dr Amar Puttanna presents the findings from the InRange study, that compares second generation basal insulins in adults with T1DM, using Time-In-Range as the primary endpoint.